gilead
Singapore Grants ‘Conditional’ Approval For Remdesivir
Singapore’s Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.
Cipla Launches Hepcvir-L For HepC Genotype 1 Patients
Hepcvir-L will be provided to patients in India at the fraction of the cost of branded Ledipasvir-Sofosbuvir under a licensing agreement with Gilead Sciences Inc.
Gilead Allows India & China To Produce Generic HIV/HBV Drug
An agreement with the Medicines Patent Pool allows generics manufacturers in India and China to produce Gilead's HBV and HIV drug, tenofovir alafenamide.
Gilead Sciences Signs HIV Generics Deal With Indian Pharmas
Gilead Sciences Inc. has signed an agreement with three Indian companies to promote access to generic versions of its HIV drug.
Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020
A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.
